alexa S Chuck | Gilead Sciences, Inc.,
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

S Chuck

Gilead Sciences, Inc., USA
Susan Chuck is the Director of Medical Affairs at Gilead Sciences in USA. Susan Chuck is Board Certified Pharmacotherapy Specialist with Added Qualifications in Infectious Diseases and also AAHIVE: AAHIVMA Certified HIV Expert and has skilled knowledge in Infectious Diseases, Virology, Clinical Research, Pharmaceutical Industry, Clinical Development, Clinical Trials, Hospital Sales, Product Launch, Medical Writing, Advisory Boards.
Research Interest
Infectious Diseases Virology Clinical Research Pharmaceutical Industry Clinical Development Clinical Trials Hospital Sales Product Launch Medical Writing Advisory Boards

Bioequivalence of the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single Tablet Regimen

A Mathias, M Menning, L Wiser, X Wei, A Dave, S Chuck and BP Kearney

Research Article: J Bioequiv Availab 2012, 4: 100-105

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version